The reporting of trials of orlistat in the 1990s appears to have understated harms, both in the summarized results submitted to the European Medicines Agency for drug approval, and in the published papers, according to a ...
0
0
It's time to regulate the use of whole body electrical stimulation, argue doctors in The BMJ today, after treating several people for muscle damage at their hospital.
0
0
The prescription only sleeping tablet zopiclone, that can become addictive if used for more than a few weeks, is easily available online, warn experts in The BMJ today.
5
0
The number of deaths associated with drugs that were subsequently withdrawn from the market could have been reduced had there been fewer delays in the withdrawal process, according to research published in the open access ...
4
0
Niranjan Lal Pathak couldn't believe his luck initially. When a doctor at a hospital in central India offered the factory watchman free treatment for a heart complaint, he jumped at the chance.
0
0
The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed ...
0
0
Encouraging interim data from the world's first clinical trial examining the safety of neural stem cell treatment in stroke patients has been reported by researchers ahead of an application for Phase II trials.
0
0
Signaling a potential breakthrough for immunization programs in resource-poor countries, researchers today announced at the American Society of Tropical Medicine and Hygiene (ASTMH) conference that regulatory authorities—after ...
0
0
Experts are calling for an urgent change to approaches for treating and researching childhood cancers, to continue to save more children from the disease.
0
1
German pharmaceuticals maker Merck KGaA said Tuesday it is withdrawing its application for its drug Erbitux to be used to treat patients with lung cancer.
0
0
Subscribe to rss feed
